Barclays Reiterates Overweight Rating on UNITEDHEALTH GROUP INCORPORATED (Delaware) (UNH)

Market Context

UNITEDHEALTH GROUP INCORPORATED (Delaware) operates in the Healthcare sector. The stock currently trades at $422.45 with a market capitalization of $305.0B. The stock has gained 30.1% over the past 52 weeks.

Analyst coverage from Barclays provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for UNITEDHEALTH GROUP INCORPORATED (Delaware).

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for UNITEDHEALTH GROUP INCORPORATED (Delaware)

Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Jul 20, 2026	Barclays	Overweight	N/A
Jul 17, 2026	RBC Capital	Outperform	N/A
Jul 17, 2026	UBS	Buy	N/A
Jul 17, 2026	Truist Securities	Buy	N/A
Jul 17, 2026	Oppenheimer	Outperform	N/A

Related Tools: Analyst Ratings Dashboard | View UNH Stock Page